Brianna 'Chickenfry' LaPaglia has left her fans in shock after an unrecognizable picture of her in college resurfaced.
An old picture of the 26–year–old content creator began circulating online this week – and many were quick to point out the seemingly drastic differences.
Recent snapshots of the brunette beauty showcase her plump pout, chiseled jawline and designer clothing.
However, the throwback photo of the podcaster, taken from her college diving and swimming team page from the 2018/2019 season, shows her in a completely different light.
In the picture, the former college athlete, who now boasts 3.6 million followers on social media, looks much younger, with long blonde hair and a slightly rounder face.
LaPaglia gave a wide smile in the college headshot, wearing a bright yellow knit shirt.
One shocked X (formerly Twitter) user shared a side–by–side of the image with a more recent picture alongside a caption that read: 'How is this the same person?'
And dozens of others were quick to flood the post with their own thoughts.
Recent snapshots of Brianna 'Chickenfry' LaPaglia showcase her plump pout, chiseled jawline and designer clothing
'"You're not ugly you're just poor" is a quote I live by lol,' joked one user.
'This is why I have trust issues,' another scathed.
'The picture on the right is her from college and now she's like 26. People tend to get hotter in their 20s.
'Plus she's had a bit of work done and has to maintain a model–esque physique as part of being an influencer,' someone else speculated.
The Plan Bri Uncut podcast host has been open about the cosmetic procedures she has undergone over the years.
In 2023, a TikTok shared by LaPaglia's surgeon, Dr Kassir, revealed she had undergone a 'revision rhinoplasty.'
The influencer has also opened up about receiving Botox and fillers.
During an appearance on season 4 of Special Forces: World's Toughest Test, also in 2023, LaPaglia spoke about beauty standards.
The throwback photo of the podcaster, taken from her college diving and swimming team page from the 2018/2019 season, shows her in a completely different light
The Plan Bri Uncut podcast host has been open about the cosmetic procedures she has undergone over the years
The social media star mentioned the work she had done in conversation with fellow competitors, with Jessie James Decker saying she might've injured herself in a challenge, noting a 'bump' on her nose at one point.
LaPaglia replied off–screen and suggested it might be 'the Italian bump,' adding 'I got mine shaved down.'
Elsewhere, at the start of June, LaPaglia opened up about undergoing emergency surgery to remove ovarian cysts in May.
A month after her surgery, she took to social media to detail a doctor's appointment.
'I just had my first post–op appointment and it went pretty well and I am okay,' she said in a video after announcing, 'This is for my girls with endometriosis or with PCOS.'
She initially disclosed the health ordeal in a TikTok video shared in May, recalling the unbearable pain that caused her to go to the emergency room.
LaPaglia said that she had experienced pain in the middle of the night after eating Taco Bell and began vomiting.
'I'm laying on the bathroom floor, literally convulsing,' she shared at the time.
After getting to the hospital, a doctor said her pain was from eating fast food but a vaginal ultrasound determined it was indeed a large cyst on her ovaries.
She stressed to her female followers, 'Women's health is so important and overlooked. I complained to my doctors for years about the severity of my periods and cramping and was always told it's nothing.'
In March, the slender content creator raised eyebrows after blasting the rampant use of trendy GLP–1 agonist drugs, particularly for non–diabetic skinny women she knows that microdose them.
'No tea, no shade, no hate, just some field research,' the social media star said.
'Every single bi**h I know is on Ozempic. People that do not need Ozempic. It's like if I did Ozempic. Could I lose a couple? Surely. Do I need Ozempic? No!'
LaPaglia concluded: 'You're gonna die. You're all gonna die!'
In 2022–2023, FDA's Adverse Event Reporting System reportedly received 49 death reports, 34 life–threatening reports and 24 disability reports for tirzepatide.
GLP–1 patients could potentially die from serious stomach problems like gastroparesis, gallbladder problems, kidney failure, pancreatitis and thyroid cancer.

By Daily Mail (U.S.) | Created at 2026-06-11 17:20:55 | Updated at 2026-06-15 21:10:34
4 days ago








